168759-64-6

Basic information

• Product Name: 7-BROMO-4-ISOCHROMANONE
• Synonyms: 7-Bromoisochroman-4-one
• CAS NO: 168759-64-6
• Molecular Formula: C9H7BrO2
• Molecular Weight: 227.05
• Mol File: 168759-64-6.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 348.7 °C at 760 mmHg
• Flash Point: 164.7 °C
• Appearance: /
• Density: 1.621 g/cm³
• Vapor Pressure: 4.93E-05mmHg at 25°C
• Refractive Index: 1.599
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 7-BROMO-4-ISOCHROMANONE(CAS DataBase Reference)
• NIST Chemistry Reference: 7-BROMO-4-ISOCHROMANONE(168759-64-6)
• EPA Substance Registry System: 7-BROMO-4-ISOCHROMANONE(168759-64-6)

Safety Data

• Hazardous Substances Data: 168759-64-6(Hazardous Substances Data)

Usage

General Description

7-Bromo-4-isochromanone is a chemical compound that belongs to the isochromanone family. It is a pale yellow solid that is primarily used as an intermediate in organic synthesis. 7-BROMO-4-ISOCHROMANONE has potential applications in pharmaceuticals and agrochemicals. It is known for its ability to act as a versatile precursor in the synthesis of various biologically active molecules. Additionally, 7-Bromo-4-isochromanone has been studied for its potential use in the development of novel drugs and as a building block in the creation of new chemical entities. Overall, this chemical compound plays a significant role in the field of organic chemistry and has the potential for various practical applications.

InChI:InChI=1/C9H7BrO2/c10-7-1-2-8-6(3-7)4-12-5-9(8)11/h1-3H,4-5H2

Upstream product

• 19477-73-7 6-bromophthalide 
• 147034-01-3 (2,5-dibromophenyl)methanol 
• 76008-76-9 2,5-dibromobenzoic acid ethyl ester 
• 670256-21-0 4-bromo-2-(hydroxymethyl)benzoic acid 
• 64169-34-2 5-bromophthalide 
• 457051-12-6 4-bromo-2-(bromomethyl)-benzonitrile 
• 67832-11-5 4-bromo-2-methylbenzonitrile 

Downstream Products

• 1337154-53-6 7-bromoisochroman-4-amine 

Relevant articles and documents

HISTONE ACETYLTRANSFERASE (HAT) INHIBITOR AND USE THEREOF

The present invention relates to a histone acetyltransferase (HAT) inhibitor. Provided are a compound represented by general formula I, a pharmaceutically acceptable salt, a stereoisomer, an enantiomer, a diastereomer, an atropisomer, a racemate, a polymorph, a solvate or an isotope-labeled compound (including deuterium substitution) thereof, a preparation method therefor, a pharmaceutical composition comprising the same, and use thereof in the treatment of various HAT-related diseases or conditions.

SPIROCYCLIC HAT INHIBITORS AND METHODS FOR THEIR USE

Compounds having a structure of Formula (IX) or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof, wherein R1, R2a, R2b, R3a, R3b, R4a, R4b, Q1----Q2, R6, R7, A, B, W, x, and y are as defined herein and are provided. Pharmaceutical compositions comprising such compounds and methods for treating various HAT-related conditions or diseases, including cancer, by administration of such compounds are also provided.

BIARYL COMPOUNDS USEFUL FOR THE TREATMENT OF HUMAN DISEASES IN ONCOLOGY, NEUROLOGY AND IMMUNOLOGY

The present invention provides compounds and compositions thereof which are useful as inhibitors of Bruton's tyrosine kinase and which exhibit desirable characteristics for the same.